Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.
J Gastroenterol Hepatol. 2012 Mar;27(3):579-85. doi: 10.1111/j.1440-1746.2011.06868.x.
Little is known about the difference between patients of chronic laryngitis with and without troublesome reflux symptoms. The aim of this study was to compare the clinical characteristics and response to acid suppression between patients of chronic laryngitis with and without troublesome reflux symptoms.
Consecutive patients with chronic laryngitis were enrolled. The frequency and severity of reflux and laryngeal symptoms were scored. All the patients underwent laryngoscopy, esophagogastroduodenoscopy and 24-h multichannel intraluminal impedance and pH monitoring before receiving rabeprazole 10 mg b.i.d. for 3 months. Mild typical reflux symptoms (heartburn or regurgitation) occurring ≥ 2 days/week or moderate/severe symptoms occurring ≥ 1 day/week were defined as troublesome reflux symptoms.
Compared to patients without troublesome reflux symptoms, those with troublesome reflux symptoms were older and had more episodes of acid and liquid gastroesophageal reflux (GER) and acid and weakly acidic laryngopharyngeal reflux (LPR). They also had higher percentages of both bolus exposure time and acid exposure time of GER and LPR. Patients with troublesome reflux symptoms responded to acid suppression more often at 12 weeks (67.3% vs 20.9%, P < 0.001) and more rapidly (40.8% vs 14.0%, 3 weeks after the start of acid suppression; P = 0.004) compared to those without.
Difference in reflux profile of GER and LPR between patients with and without troublesome reflux symptoms could partly explain the discrepancy of response to acid suppression among patients with chronic laryngitis. Acid suppression therapy may provide limited therapeutic benefits to patients of chronic laryngitis without troublesome reflux symptoms.
对于伴有和不伴有烦扰性反流症状的慢性喉炎患者之间的差异,人们知之甚少。本研究旨在比较伴有和不伴有烦扰性反流症状的慢性喉炎患者的临床特征和抑酸反应。
连续纳入慢性喉炎患者。反流和喉症状的频率和严重程度均进行评分。所有患者在接受雷贝拉唑 10 mg,bid,治疗 3 个月前,均行喉镜、食管胃十二指肠镜检查以及 24 小时多通道腔内阻抗和 pH 监测。定义轻度典型反流症状(烧心或反流)每周≥2 天或中重度症状每周≥1 天为烦扰性反流症状。
与不伴有烦扰性反流症状的患者相比,伴有烦扰性反流症状的患者年龄更大,酸和液体胃食管反流(GER)以及酸和弱酸性喉咽反流(LPR)发作次数更多。他们的 GER 和 LPR 的食团暴露时间和酸暴露时间百分比也更高。烦扰性反流症状患者在 12 周时对抑酸治疗的反应更频繁(67.3%比 20.9%,P<0.001),且反应更快(开始抑酸治疗 3 周时,40.8%比 14.0%,P=0.004)。
伴有和不伴有烦扰性反流症状的患者 GER 和 LPR 的反流特征差异可能部分解释了慢性喉炎患者对抑酸治疗反应的差异。抑酸治疗可能对不伴有烦扰性反流症状的慢性喉炎患者提供有限的治疗益处。